Marianna Fontana

2007–2025 年に発表

226
論文数
29,791
被引用数
90
h 指数
208
i10 指数

被引用数

Marianna Fontana の年別被引用数2003 年: 被引用 1 件2004 年: 被引用 2 件2007 年: 被引用 2 件2009 年: 被引用 4 件2010 年: 被引用 16 件2011 年: 被引用 7 件2012 年: 被引用 5 件2013 年: 被引用 39 件2014 年: 被引用 83 件2015 年: 被引用 87 件2016 年: 被引用 167 件2017 年: 被引用 160 件2018 年: 被引用 165 件2019 年: 被引用 708 件2020 年: 被引用 993 件2021 年: 被引用 1,279 件2022 年: 被引用 1,563 件2023 年: 被引用 1,253 件2024 年: 被引用 2,223 件2025 年: 被引用 1,279 件2026 年: 被引用 20 件2005〜2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,064 件、この内訳の 22%イギリス: 引用元論文 1,101 件、この内訳の 11.8%イタリア: 引用元論文 799 件、この内訳の 8.5%ドイツ: 引用元論文 532 件、この内訳の 5.7%中国: 引用元論文 520 件、この内訳の 5.6%フランス: 引用元論文 344 件、この内訳の 3.7%カナダ: 引用元論文 338 件、この内訳の 3.6%オランダ: 引用元論文 321 件、この内訳の 3.4%スペイン: 引用元論文 288 件、この内訳の 3.1%日本: 引用元論文 226 件、この内訳の 2.4%オーストラリア: 引用元論文 222 件、この内訳の 2.4%スイス: 引用元論文 205 件、この内訳の 2.2%
0%22%その他 25.6%

分野

  • Medicine52.3%
  • Biochemistry, Genetics and Molecular Biology43.8%
  • Immunology and Microbiology1.3%
  • Engineering1%
  • Computer Science0.3%
  • Materials Science0.2%
  • その他1.1%

トピック

  • Amyloidosis: Diagnosis, Treatment, Outcomes10.3%
  • Cardiac Imaging and Diagnostics6%
  • Cardiovascular Function and Risk Factors4.9%
  • SARS-CoV-2 and COVID-19 Research4.2%
  • Parathyroid Disorders and Treatments3.6%
  • COVID-19 Clinical Research Studies3.5%
  • その他67.5%

共著者

全論文

検索で開く
  1. CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 1,633

  2. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 被引用: 1,145

  3. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudio Rapezzi, Philip N. Hawkins - Circulation 2016 被引用: 2,011

  4. A new staging system for cardiac transthyretin amyloidosis

    著者: , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 740

  5. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 461

  6. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jihong Chen, Elena Yureneva, Marianne T. Sweetser, Patrick Y. Jay, Pushkal Garg, John Vest, Julian D. Gillmore - New England Journal of Medicine 2023 被引用: 307

  7. Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 515

  8. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena Yureneva, Nancy Silliman, Lilli Yang, Jihong Chen, Satish A. Eraly, John Vest, Mathew S. Maurer - New England Journal of Medicine 2024 被引用: 362

  9. Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 被引用: 229

  10. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2021 被引用: 333

  11. Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgina L. Baca, Sasha N. L. Bailey, Anish Bhuva, Alex Boulter, Ruth Bowles, Rosemary J. Boyton, Olivia V. Bracken, Benjamin O’Brien, Tim Brooks, Natalie Bullock, David K. Butler, Gabriella Captur, Olívia Carr, Nicola Champion, Carmen K. M. Chan, Aneesh Chandran, Tom W. Coleman, Jorge Couto de Sousa, Xosé Couto‐Parada, Eleanor R. Cross, Teresa Cutiño‐Moguel, Silvia D’Arcangelo, Rhodri Davies, Brooke Douglas, Cecilia Di Genova, Keenan Dieobi-Anene, Mariana O. Diniz, Anaya Ellis, Karen Feehan, Malcolm Finlay, Marianna Fontana, Nasim Forooghi, Sasha Francis, Joseph M. Gibbons, David Gillespie, Derek W. Gilroy, Matt Hamblin, Gabrielle Harker, Georgia Hemingway, Jacqueline Hewson, Wendy Heywood, Lauren M. Hickling, Bethany Hicks, Aroon D. Hingorani, Lee Hamill Howes, Ivie Itua, Victor Jardim, Wing-Yiu Jason Lee, Melaniepetra Jensen, Jessica Jones, Meleri Jones, George Joy, Vikas Kapil, Caoimhe Kelly, Hibba Kurdi, Jonathan Lambourne, Kai-Min Lin, Siyi Liu, Aaron Lloyd, Sarah Louth, Mala K. Maini, Vineela Mandadapu, Charlotte Manisty, Áine McKnight, Katia Menacho, Celina Mfuko, Ken Mills, Sebastian Millward, Oliver Mitchelmore, Christopher Moon ほか 48 名 - Science 2022 被引用: 359

  12. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hakam Abbass, Aderonke Abiodun, Mashael Alfarih, Zoe Alldis, Mervyn Andiapen, Jessica Artico, João B. Augusto, Georgina L. Baca, Sasha N. L. Bailey, Anish Bhuva, Alex Boulter, Ruth Bowles, Rosemary J. Boyton, Olivia V. Bracken, Benjamin O’Brien, Tim Brooks, Natalie Bullock, David K. Butler, Gabriella Captur, Nicola Champion, Carmen K. M. Chan, David Collier, Jorge Couto de Sousa, Xosé Couto‐Parada, Teresa Cutino-Mogue, Rhodri Davies, Brooke Douglas, Cecilia Di Genova, Keenan Dieobi-Anene, Anaya Ellis, Karen Feehan, Malcolm Finlay, Marianna Fontana, Nasim Forooghi, Celia Gaier, Derek W. Gilroy, Matt Hamblin, Gabrielle Harker, Jacqueline Hewson, Lauren M. Hickling, Aroon D. Hingorani, Lee Hamill Howes, Alun D. Hughes, Gemma Hughes, Rebecca Hughes, Ivie Itua, Victor Jardim, Wing-Yiu Jason Lee, Melanie Jensen, Jessica Jones, Meleri Jones, George Joy, Vikas Kapil, Hibba Kurdi, Jonathan Lambourne, Kai‐Min Lin, Sarah Louth, Vineela Mandadapu, Áine McKnight, Katia Menacho, Celina Mfuko, Oliver Mitchelmore, Christopher Moon, Diana Mūnoz Sandoval, Sam M. Murray, Mahdad Noursadeghi, Ashley Otter, Susana Palma, Ruth Parker, Kush Patel ほか 34 名 - Nature 2021 被引用: 426

  13. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , - Circulation Heart Failure 2019 被引用: 546

  14. Conventional heart failure therapy in cardiac ATTR amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 137

  15. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Imaging 2019 被引用: 475

  16. Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 被引用: 356

  17. RNA-targeting and gene editing therapies for transthyretin amyloidosis

    著者: , , , , , , , , , - Nature Reviews Cardiology 2022 被引用: 160

  18. SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julian D. Gillmore, Marianna Fontana - Journal of the American College of Cardiology 2024 被引用: 139

  19. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2015 被引用: 610

  20. Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2022 被引用: 167

  21. Transthyretin cardiac amyloidosis

    著者: , , - Cardiovascular Research 2022 被引用: 163

  22. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction

    著者: , , , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2019 被引用: 255

  23. Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression

    著者: , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2020 被引用: 195

  24. Magnetic Resonance in Transthyretin Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 被引用: 425